Stemirna Therapeutics
PrivateLast Round
Series D
May 25, 2023
Est. Valuation
$308.9M
Total Funding Raised
$238.5M
Company Overview
Stemirna Therapeutics is a biotechnology company that develops mRNA-based vaccines and therapeutics for infectious diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stemirna Therapeutics Comparables
Compare Stemirna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai RNACure Biopharma Co., Ltd. | 87% | |
| Abogen Biosciences | 86% | |
| WestGene Biopharma | 86% | |
Stemirna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 25, 2023 | ||||
| Strategic | Aug 27, 2021 | ||||
| Series C | Jun 1, 2021 | ||||
| Series B | Dec 1, 2020 | ||||
| Series A Extension | Feb 7, 2020 | ||||
Series A | Jul 1, 2019 |
Stemirna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 招银国际金融有限公司 | Series C |
| Shanghai Zhangjiang Torch Venture Capital | Series A |
| Greenwoods Investments | Series C |
| OrbiMed | Series C |
| Forebright Capital | Series C |
| Advantech Capital | Series C |
| CITIC Securities Investment | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2019
$14M round with participation from Jiuyo Capital Management.
Stemirna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stemirna Therapeutics's valuation, stock price, and market status.